Last reviewed · How we verify
recombinant FSH or hMG — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
recombinant FSH or hMG (recombinant FSH or hMG) — Yazd Research & Clinical Center for Infertility.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| recombinant FSH or hMG TARGET | recombinant FSH or hMG | Yazd Research & Clinical Center for Infertility | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- recombinant FSH or hMG CI watch — RSS
- recombinant FSH or hMG CI watch — Atom
- recombinant FSH or hMG CI watch — JSON
- recombinant FSH or hMG alone — RSS
Cite this brief
Drug Landscape (2026). recombinant FSH or hMG — Competitive Intelligence Brief. https://druglandscape.com/ci/recombinant-fsh-or-hmg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab